How do you pay?

How to pay the least

Ask for the cash price

Lunsumio Velo

Lunsumio Velo is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Lunsumio Velo’s cash price, and one or two other pharmacies too.
  2. Lunsumio Velo’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameLunsumio Velo
Authorized genericmosunetuzumab
Regular genericmosunetuzumab
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Lunsumio Velo?
The original
–
–

Brand nameThe maker’s card

Genentech Oncology Co-pay Assistance Program

Savings card from Genentech

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a treatment

The card takes up to $25,000 a year off your co-pay.

Sign up on lunsumio.com 

Or call 1-888-249-4918.

In the maker’s words

“With the Genentech Oncology Co-pay Assistance Program, eligible patients with commercial insurance could pay as little as $0 per treatment for LUNSUMIO or LUNSUMIO VELO.”

From the maker’s offer on lunsumio.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Lunsumio Velo itself, from the same company, sold without the brand name, and usually for less. For now Lunsumio Velo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Lunsumio Velo is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

LUNSUMIO VELO is a bispecific CD20-directed CD3 T-cell engager indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy.

This indication is approved under accelerated approval based on response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).

Source: the FDA label for Lunsumio Velo (Genentech, Inc.), June 29, 2026. Full label on DailyMed 

Good to know